Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$401M |
| 2 |
NVIDIA
NVDA
|
+$333M |
| 3 |
Costco
COST
|
+$236M |
| 4 |
Amazon
AMZN
|
+$215M |
| 5 |
Johnson & Johnson
JNJ
|
+$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$322M |
| 2 |
Super Micro Computer
SMCI
|
+$284M |
| 3 |
JPMorgan Chase
JPM
|
+$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
+$160M |
| 5 |
Intel
INTC
|
+$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
GDS Holdings
GDS
$6.42B
| $3.33M | ﹤0.01% |
163,072
-4,561
| -3% | -$93.1K |
|
2652
Marathon Digital Holdings
MARA
$5.88B
| $3.31M | ﹤0.01% |
203,841
-3,033,079
| -94% | -$49.2M |
|
2653
Bowman Consulting
BWMN
$703M
| $3.3M | ﹤0.01% |
137,237
+60,656
| +79% | +$1.46M |
|
2654
Ardagh Metal Packaging
AMBP
$2.1B
| $3.3M | ﹤0.01% |
875,985
+126,132
| +17% | +$476K |
|
2655
C4 Therapeutics
CCCC
$188M
| $3.3M | ﹤0.01% |
578,885
-40,227
| -6% | -$229K |
|
2656
Erasca
ERAS
$440M
| $3.3M | ﹤0.01% |
1,208,299
+708,241
| +142% | +$1.93M |
|
2657
Bioventus
BVS
$468M
| $3.29M | ﹤0.01% |
275,111
+157,615
| +134% | +$1.88M |
|
2658
SB Financial Group
SBFG
$136M
| $3.28M | ﹤0.01% |
159,695
+1,387
| +0.9% | +$28.5K |
|
2659
Plumas Bancorp
PLBC
$313M
| $3.27M | ﹤0.01% |
80,270
+1,120
| +1% | +$45.7K |
|
2660
Stoke Therapeutics
STOK
$1.24B
| $3.26M | ﹤0.01% |
265,010
+73,650
| +38% | +$905K |
|
2661
Aldeyra Therapeutics
ALDX
$333M
| $3.26M | ﹤0.01% |
604,041
-68,016
| -10% | -$367K |
|
2662
eXp World Holdings
EXPI
$1.76B
| $3.24M | ﹤0.01% |
229,579
-10,520
| -4% | -$148K |
|
2663
AnaptysBio
ANAB
$637M
| $3.22M | ﹤0.01% |
95,972
-239,962
| -71% | -$8.04M |
|
2664
Bank7 Corp
BSVN
$460M
| $3.2M | ﹤0.01% |
85,312
+7,019
| +9% | +$263K |
|
2665
BlackBerry
BB
$2.25B
| $3.2M | ﹤0.01% |
1,219,818
-602,977
| -33% | -$1.58M |
|
2666
Holley
HLLY
$360M
| $3.17M | ﹤0.01% |
1,075,974
+100,940
| +10% | +$298K |
|
|
AGR
2667
DELISTED
Avangrid, Inc.
AGR
| $3.14M | ﹤0.01% |
87,688
-172,102
| -66% | -$6.16M |
|
2668
OptimizeRx
OPRX
$326M
| $3.12M | ﹤0.01% |
404,427
+80,297
| +25% | +$620K |
|
2669
Five Point Holdings
FPH
$412M
| $3.11M | ﹤0.01% |
749,846
+92,012
| +14% | +$382K |
|
2670
10x Genomics
TXG
$1.57B
| $3.1M | ﹤0.01% |
137,338
-77,754
| -36% | -$1.76M |
|
2671
McCormick & Company Voting
MKC.V
$18.4B
| $3.1M | ﹤0.01% |
37,521
+100
| +0.3% | +$8.26K |
|
2672
Flutter Entertainment
FLUT
$51.2B
| $3.09M | ﹤0.01% |
+13,040
| New | +$3.09M |
|
2673
Astria Therapeutics
ATXS
$423M
| $3.09M | ﹤0.01% |
280,313
+134,155
| +92% | +$1.48M |
|
2674
AMCON Distributing
DIT
$76.1M
| $3.07M | ﹤0.01% |
21,182
| – | – |
|
2675
GrowGeneration
GRWG
$89.1M
| $3.05M | ﹤0.01% |
1,431,702
+20,615
| +1% | +$43.9K |
|